Correction to Earlier Release From Jewish Hospital and University of Louisville

LOUISVILLE, Ky., July 24 /PRNewswire-USNewswire/ -- In today's announcement regarding the use of stem cells in the treatment of heart failure, we failed to make a critical distinction. Louisville researchers and physicians have performed the world's first phase-one FDA-approved clin...

First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

WISCONSIN RAPIDS, Wis., July 23 /PRNewswire/ -- Earlier this month the University of Wisconsin Cancer Center Riverview became the first medical facility in the world to treat patients with a breakthrough treatment of skin cancer. Located within Riverview Hospital, Wisconsin Rapids, ...

Infant Formula Company Teams With the University of Virginia Pediatrics Department to Conduct Clinical Studies

GORDONSVILLE, Va., June 24 /PRNewswire/ -- PBM Products, LLC, a leading infant formula company that supplies store-brand infant formulas to Walmart, Sam's Club, Target, Kroger, CVS, Walgreens, and other retailers, has partnered with the University of Virginia (U.Va.) to conduct clinical studies ...

Single Port Surgeries Now Performed at University Medical Center at Princeton

Advances Trend Toward Less-Invasive Approaches PRINCETON, N.J., June 8 /PRNewswire/ -- Advancing the trend toward ever less invasive surgery, University Medical Center at Princeton ( www.princetonhcs.org ) is now performing laparoscopic surgery by way of a single incision through the belly ...

Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient

ANN ARBOR, Mich., March 9 /PRNewswire/ -- Terumo Heart, Inc. today announced that NewYork-Presbyterian Hospital/ Columbia University Medical Center recently became the second U.S. center, and first in the Northeast, to implant the DuraHeart(TM) Left-Ventricular Assist System as part of the DuraHe...

Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration

CALGARY, Feb. 4 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY ) and the Cancer Therapy & Research Center at The University of Texas Health Science Center in San Antonio, (CTRC at UTHSCSA) announced a broad preclinical and clinical collaboration invol...

British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection

University of Nottingham Scientists Leading Major Study into Lethal 'Super' Strains of C.difficile CHICAGO, Jan. 28 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham are leading a major European study to unravel the ...

WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System

UT Southwestern to Identify and Validate Novel Gene Expression Biomarkers Involved in Wound Healing with Innovative Gene Expression Platform FREMONT, Calif., Jan. 8 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art gene exp...

InteRNA Technologies and VU University Medical Center to Develop microRNA-Based Diagnostics and Therapeutics for Cancer

BILTHOVEN and AMSTERDAM, The Netherlands, October 30 /PRNewswire/ -- InteRNA Technologies B.V. and VU university medical center in Amsterdam, VUmc, announce today the signing of a framework research agreement to develop microRNA (miRNA)-based diagnostics and therapeutics for cancer using InteR...

Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report

DRS. PATRICIA BERG AND ARNOLD SCHWARTZ LED TEAM, Article in Modern Pathology set for print publication January 2009 BERG HAD ALSO DISCOVERED SAME GENE'S ACTIVATION IN MAJORITY OF BREAST CANCER CASES WASHINGTON, Oct. 24 /PRNewswire-USNewswire/ -- A gene has been found activated in 70% of pr...

American College of Cardiology and Center of Excellence for Simulation Research of Western Michigan University (CESR) Partner for in situ Simulation to Improve Team Communication and Door-to-Balloon (D2B) Time

WASHINGTON, BATTLE CREEK, Mich., and EVANSTON, Ill., Oct. 20 /PRNewswire/ -- The American College of Cardiology (ACC) and the Center of Excellence for Simulation Research (CESR) of Western Michigan University announced the launch of an educational and research partnership, using in situ simula...

Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay

The Study Will Compare the Results of Rosetta Genomics' microRNA-based Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous non Small Cell Lung Cancer, With Current Diagnostic Methods A Test Based on the miRview(TM) Technology First Approved for Clinical use Thro...

Queen's University Chooses Xceed's Ziplex(R) System for Translational Research

Study to validate gene signature designed to predict outcomes in follicular lymphoma WELLESLEY, Mass., Sept. 15 /PRNewswire/ -- Xceed Molecular, a pioneer in the development of cost-effective, easy-to-use gene-expression analysis systems, announced that Queen's Uni...

deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer

Detection may be used to complement and target screening for the disease; findings will be integrated into the deCODEme(TM) personal genome scan. REYKJAVIK, Iceland, Sept. 14 /PRNewswire-FirstCall/ -- Scientists at deCODE genetics (Nasdaq: DCGN ) and colleagues at Radboud University Medical ...

The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research

Award Winning Research Team Makes Crucial Breakthrough in Battle to Prevent Onset of Parkinson's Disease CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthr...

Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services

BOSTON, Aug. 18 /PRNewswire-USNewswire/ -- Boston University and Aubrey Milunsky, MB.B.Ch, D.Sc., President of the Center for Human Genetics, Inc. ("CHG") and Director of the Center for Human Genetics of Boston University, announced that CHG will no longer offer testing services covered by pat...

First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan

National trial aims to help heart failure patients survive until transplant, and may offer lower clot risk and less blood damage than earlier heart devices ANN ARBOR, Mich., Aug. 5 /PRNewswire-USNewswire/ -- Anthony Shannon made history on July 30. That's when he became the first person in t...

Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial

ANN ARBOR, Mich., June 25 /PRNewswire/ -- Terumo Heart, Inc. announced today approval from the Institutional Review Board (IRB) at the University of Michigan to move forward with the DuraHeart(TM) Left Ventricular Assist System (LVAS) U.S. Pivotal Trial for a Bridge-to-Transplant (BTT) indicat...

CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model

BOTHELL, Wash., June 3 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) has selected the Cardiovascular Phenotyping Core at Washington University School of Medicine in St. Louis to perform a study to further evaluate CellCyte's glycoprotein products...

Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany

Dr. Mielke Continues his Collaboration With Kiadis Pharma on ATIR(TM) AMSTERDAM, May 29 /PRNewswire/ -- Biopharmaceutical company Kiadis Pharma announces today the clinical development collaboration for its lead product ATIR(TM) with Dr. Stephan Mielke and Professor Dr. Hermann Einsele from t...

Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists

Routine Safety Study That Government Scientists Refused To Do Illustrates Vaccine Program And Mercury Health Risks Says SafeMinds ATLANTA, May 19 /PRNewswire-USNewswire/ -- Findings released Friday showed that infant monkeys given vaccines officially recommended by the CDC and the American...

Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center

NEW YORK, April 25 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ) announced today that the Institutional Review Board (IRB) of the University of Maryland Medical Center (UMMC) has approved UMMC's participation in the Phase III study of the Company's Percutaneous Hepatic Perfu...

Vermillion and the Ohio State University Report That Novel Diagnostic Test May Help Predict Risk for Relapse of TTP, A Serious Blood Disorder

- Findings Published in the British Journal of Hematology - FREMONT, Calif., April 24 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ) today reported findings from an Ohio State University (OSU) clinical study that indicated that a surface-enhanced laser desorption/ionization ...

Wayne State University and Oakwood Partner in New Device to Combat Congestive Heart Failure

DEARBORN, Mich., April 7, 2008 /PRNewswire-USNewswire/ -- Wayne State University School of Medicine and Oakwood Healthcare System surgeons successfully implanted a new device designed to combat congestive heart failure in a 49-year-old patient. The device could become a leading tool in the ars...

Columbia University Medical Center and Rosetta Genomics Announce Columbia University's Submission of the First Cancer Diagnostic Test Based on Rosetta Genomics Proprietary MicroRNA Technology for Approval to the New York State Department of Health Clinica

The Laboratory-Developed Test is Designed to Differentiate Squamous From Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Classifying Squamous Cell Carcinoma of the Lung With Sensitivity of 96 Percent and Specificity of 90 Percent. Accurate Diagnosis is Importa...

Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development

SAN DIEGO, April 3, 2008 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced that it has been awarded a two-year, $2.0 million Phase II Small Business Technology Transfer (STTR) grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the N...

UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies

COLLEGE PARK, Md., Feb. 21 /PRNewswire-USNewswire/ -- The University of Maryland's Maryland Industrial Partnerships Program (MIPS) today announces the approval of 18 new collaborative research projects between Maryland companies and university faculty. Worth $4.4 million, the new projects ...

Beckman Coulter Announces Licensing Agreements for Molecular Tests with National University of Ireland, Galway

Contracts Give Access to Diagnostic Application of Research Technologies FULLERTON, Calif., Jan. 22 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ) announced today that it has signed four agreements with National University of Ireland, Galway (NUI Galway) to direct assay research...

Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania

First Patients Enrolled and Being Treated BETHESDA, Md., Dec. 27 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. (OTC Bulletin Board: NWBO) (AIM: NWBT; NWBS) ("NWBT") today announced that a Phase I/II clinical trial in at least 30 patients, using DCVax(R)-L for recurre...

Raydiance Collaborates With Rutgers University and Nation's Largest Tissue Bank to Develop Innovative Tissue Processing Approaches

Scientists Leveraging Precision and Power of Raydiance USP Laser Platform to Separate Skin Layers Without Collateral Damage; Decontaminate Tissue; Speed Tissue Cleaning Initial Proof of Concept Testing Successful During Feasibility Trials PETALUMA, Calif. and NEW BR...

Tezampanel, TorreyPines Therapeutics' Lead Compound, Reduced Muscle Spasticity and Rigidity in Preclinical Study Conducted at University of California, San Diego

Data Suggest Potential for Treating Motor System Disorders LA JOLLA, Calif., Oct. 17 /PRNewswire/-- Tezampanel, a novel small molecule currently in clinical development by TorreyPines Therapeutics, Inc. (Nasdaq: TPTX ) for the treatment of acute migraine headache, was shown in an indep...

Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers

Results presented today at American College of Gastroenterology's Annual Meeting COLLEGE PARK, Md., Oct. 16 /PRNewswire-USNewswire/ -- A clinical trial conducted by University of Maryland School of Medicine researchers and CSA Medical Inc. may yield a breakthrough treatment for pre-cancerous...

Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss

Quark Expands Hearing Loss Program With Novel SiRNA Approaches To Noise- Induced Hearing Loss With Its First Drug Candidate, AHLI-11, For The Prevention Of Chemotherapy-Induced Hearing Loss In Late Pre-IND Stage FREMONT, Calif., Sept. 24 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clini...

Boston University Biomedical Engineers Find Chink in Bacteria's Armor

Find Could Lead to More Effective Antibiotics Against 'Superbugs' BOSTON, Sept. 6 /PRNewswire-USNewswire/ -- Biomedical researchers at Boston University's College of Engineering may have discovered the path toward developing better drugs capable of defeating so-called "superbugs," bacteria t...

Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss

Quark's First Hearing Loss Compound, AHLi-11, Slated for IND Filing By Year- End 2007 FREMONT, Calif., Aug. 20 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel RNA interference-based...

Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University

UPPSALA, Sweden, January 13 /PRNewswire/ -- Beactica AB, the Swedish fragment-based drug discovery company, today announced a new research collaboration agreement with GE Healthcare (Chalfont St. Giles, UK), the world leading provider of molecular interaction analysis tools, and Uppsala Unive...

Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University

ST. LOUIS, June 11 /PRNewswire/ -- Orion Genomics announced today that the company entered into a worldwide exclusive license agreement with The Johns Hopkins University (JHU) to commercialize products that identify patients at risk for colorectal cancer. The license is based on a suite of iss...

BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University

- Opening celebrated with inaugural Symposium on Biofilms CAMBRIDGE, Mass. and LUDWIGSHAFEN, Germany, April 29 /PRNewswire/ -- BASF today announced the official launch of the BASF Advanced Research Initiative at Harvard University. The Advanced Research Initiative at Harvard University ...

Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University

BOCA RATON, Fla., Jan. 11 /PRNewswire-USNewswire/ -- Florida Atlantic University and Scripps Florida will present the 2008 Distinguished Nobel Laureate Lecture on Wednesday, January 16 from 4-5:30 p.m. in the University Theatre, 777 Glades Road, Boca Raton. Gunter Blobel, M.D., Ph.D. is the 19...

Alnylam and Stanford University Scientists Discover New Role for microRNAs (miRNAs) in T Cell Biology and Immunity

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar 22, 2007 - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today publication of a study in the journal Cell by Alnylam and Stanford University scientists on the role of miRNAs in immunity. In the pre-clinical study,...